RECURRENT ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE

Clinical trials for RECURRENT ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE trials appear

Sign up with your email to follow new studies for RECURRENT ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for babies with aggressive leukemia: targeted drug trial underway

Disease control Ongoing

This study is testing whether adding a new oral drug called revumenib to standard chemotherapy is safe and effective for infants and young children with a specific, high-risk type of leukemia that has come back or hasn't responded to previous treatments. The trial aims to find th…

Matched conditions: RECURRENT ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE

Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

RECURRENT ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE

Get alerted when new RECURRENT ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE trials appear

New hope for babies with aggressive leukemia: targeted drug trial underway